MRSAid | A novel, non-antibiotic system for nasal bacterial decolonization to reduce the incidence of hospital-acquired infections (HAI’s).
MRSAid is a novel non-antibiotic therapy developed for use in hospital/long-term care settings for nasal decolonization of potentially pathogenic bacteria, including MRSA. Developed by Ondine Biomedical Inc., the global leaders in antimicrobial photodynam
MRSAid, nasal decolonization, mrsa, infections, photodisinfection, hospital aquired infection, therapy, non-antiobiotic, ondine, ondine biomedical
Is this your site? Certify your site and update informations
